<html>
<head>PUBMED IDs for neurosin</head>
<body bgcolor='#C5F0F2'><h1>neurosin</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9003450/'>Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain.</a> January 3  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10485467/'>Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.</a> September 15  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10610719/'>Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease.</a> December 28  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10675891/'>The new human kallikrein gene family: implications in carcinogenesis.</a> February 17  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11018688/'>Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.</a> October 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11124344/'>Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma.</a> December 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11388408/'>Characterization of a brain-related serine protease, neurosin (human kaillikrein 6), in human cerebrospinal fluid.</a> June 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11388392/'>Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy.</a> June 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11388371/'>The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease.</a> June 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11668196/'>The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry.</a> October 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12016211/'>The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family.</a> May 23  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12589961/'>Role of kallikrein enzymes in the central nervous system.</a> February 19  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12624642/'>Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis.</a> March 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12928483/'>Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.</a> August 21  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14531278/'>[Kallikrein-family serine protease in the central nervous system].</a> October 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15207701/'>Cloning and characterization of novel isoforms of the human kallikrein 6 gene.</a> June 23  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15255184/'>Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.</a> July 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15305183/'>Characterisation of human kallikrein 6/protease M expression in ovarian cancer.</a> August 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/22473712/'>Regulation of Î±-synuclein expression in Down syndrome.</a> October 6  2012<br></body></html>
